PCRX Insider Trading

Insider Ownership Percentage: 6.40%
Insider Buying (Last 12 Months): $136,240.40
Insider Selling (Last 12 Months): $653,601.25

Pacira BioSciences Insider Trading History Chart

This chart shows the insider buying and selling history at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$16ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Pacira BioSciences Share Price & Price History

Current Price: $24.91
Price Change: Price Decrease of -0.39 (-1.54%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for PCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$24.91Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Pacira BioSciences (NASDAQ:PCRX)

99.73% of Pacira BioSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$106Mbought$154MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M$0$100MTotal InflowsTotal Outflows
Pacira BioSciences logo
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Read More on Pacira BioSciences

Today's Range

Now: $24.91
Low: $24.52
High: $25.88

50 Day Range

MA: $24.76
Low: $22.04
High: $27.25

52 Week Range

Now: $24.91
Low: $11.16
High: $31.67

Volume

586,571 shs

Average Volume

937,280 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.86

Who are the company insiders with the largest holdings of Pacira BioSciences?

Pacira BioSciences' top insider shareholders include:
  1. David M Stack (CEO)
  2. Gary W Pace (Director)
  3. Daryl Gaugler (COO)
  4. Frank D Lee (CEO)
  5. Kristen Williams (Insider)
  6. Jonathan Slonin (Insider)
  7. Roy Winston (Insider)
  8. Lauren Riker (SVP)
  9. Charles A Reinhart III (CFO)
  10. Kristen Marie Williams (Insider)
  11. Lauren Bullaro Riker (SVP)
  12. Mark A Kronenfeld (Director)
  13. Mark Froimson (Director)
  14. Paul J Hastings (Director)
  15. Marcelo Bigal (Director)
Learn More about top insider investors at Pacira BioSciences.

Who are the major institutional investors of Pacira BioSciences?

Pacira BioSciences' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.40%
  2. Pacer Advisors Inc. — 7.07%
  3. Renaissance Technologies LLC — 4.32%
  4. Dimensional Fund Advisors LP — 3.97%
  5. Geode Capital Management LLC — 2.37%
  6. Point72 Asset Management L.P. — 2.33%
Learn More about top institutional investors of Pacira BioSciences stock.

Which institutional investors are selling Pacira BioSciences stock?

In the last quarter, PCRX stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
  2. Invesco Ltd.
  3. Arrowstreet Capital Limited Partnership
  4. Marshall Wace LLP
  5. Cubist Systematic Strategies LLC
  6. Trexquant Investment LP
  7. AQR Capital Management LLC
  8. Schonfeld Strategic Advisors LLC
During the previous year, company insiders that have sold Pacira BioSciences company stock include:
  1. David M Stack (CEO)
  2. Gary W Pace (Director)
  3. Daryl Gaugler (COO)
  4. Frank D Lee (CEO)
  5. Kristen Williams (Insider)
Learn More investors selling Pacira BioSciences stock.

Which institutional investors are buying Pacira BioSciences stock?

During the previous quarter, PCRX stock was purchased by institutional investors including:
  1. Point72 Asset Management L.P.
  2. Jacobs Levy Equity Management Inc.
  3. Balyasny Asset Management L.P.
  4. Nuveen Asset Management LLC
  5. Ameriprise Financial Inc.
  6. ExodusPoint Capital Management LP
  7. Northern Trust Corp
  8. Norges Bank
In the previous year, these company insiders have bought Pacira BioSciences stock:
  1. David M Stack (CEO)
  2. Gary W Pace (Director)
  3. Daryl Gaugler (COO)
Learn More investors buying Pacira BioSciences stock.